Mass Spectrometry for the Evaluation of Cardiovascular Diseases Based on Proteomics and Lipidomics.

Mass Spectrometry for the Evaluation of Cardiovascular Diseases Based on Proteomics and Lipidomics. A. Thomas*, S. Lenglet, P. Chaurand*, J. Deglon, P. Mangin, F. Mach, S. Steffens, J-L. Wolfender and C. Staub. Thrombosis & Haemostasis, Vol. 106, 20-33 (2011). 

Ce contenu a été mis à jour le 1 février 2023 à 1 h 35 min.